BioCentury
ARTICLE | Company News

Quest Diagnostics sales and marketing update

August 1, 2011 7:00 AM UTC

Quest launched its spinal muscular atrophy (SMA) testing services in the U.S. to diagnose SMA in patients. The tests detect defective survival of motor neuron 1 telomeric (SMN1) and the number of cop...